• Artículo
      Icon

      Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib 

      Rodríguez Gil, Alfonso; Escamilla Gómez, Virginia; Nufer, Melanie; Andújar Sánchez, Félix; Lopes Ramos, Teresa; Bejarano García, José Antonio; Caballero Velázquez, Teresa; Villadiego Luque, Francisco Javier; Pérez Simón, José Antonio (Nature Publishing Group, 2022)
      Donor derived regulatory T lymphocytes and the JAK1/2 kinase inhibitor ruxolitinib are currently being evaluated as ...
    • Artículo
      Icon

      Delayed administration of ixazomib modifies the immune response and prevents chronic graft-versus-host disease 

      Ramos, Teresa L.; García Guerrero, Estefanía; Caballero Velázquez, Teresa; Rodríguez Gil, Alfonso; Caracuel García, Rocío; Nufer, Melanie; Robles Frías, María José; Barbado González, Mª Victoria; Pérez Simón, José Antonio (Nature Publishing Group, 2021-09-23)
      In this study, we aimed to modify the immune response in the long term after allogeneic bone marrow transplantation ...